On BCG Vaccine Protection from COVID-19: A Review.

Content Provider	Europe PMC
Author	Bagheri, Narges Montazeri, Hesam
Abstract	Bacille Calmette-Guérin (BCG) vaccine has been globally used to protect infants against tuberculosis (TB) for about a century. This vaccine has been shown to provide some degree of non-specific protection from other respiratory tract infections. This advantage has encouraged researchers to investigate the potential protection of this vaccine from the coronavirus disease 2019 from different perspectives in the ongoing pandemic. In this study, we have comprehensively reviewed the latest articles on potential vaccine effectiveness of BCG on COVID-19 and summarized the possible impacts of the BCG against SARS-COV-2 in detail.
Related Links	https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7956872&blobtype=pdf
Journal	Sn Comprehensive Clinical Medicine [SN Compr Clin Med]
Volume Number	3
DOI	10.1007/s42399-021-00835-1
PubMed Central reference number	PMC7956872
Issue Number	6
PubMed reference number	33748676
e-ISSN	25238973
Language	English
Publisher	Springer International Publishing
Publisher Date	2021-03-15
Publisher Place	Gewerbestrasse 11, Cham, Ch 6330, Switzerland
Access Restriction	Open
Rights License	This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. © The Author(s), under exclusive licence to Springer Nature Switzerland AG part of Springer Nature 2021
Subject Keyword	BCG vaccine COVID-19 Non-specific vaccine protection Tuberculosis
Content Type	Text
Resource Type	Article
Subject	Medicine